Stem Cell Revolution

More than 90% of drugs that enter clinical trials never reach FDA approval. In regenerative medicine and stem cell research, that statistic is often misunderstood. A missed endpoint does not always mean mesenchymal stem cells failed. Sometimes the dose, the patient group, or the measurement itself was wrong. 🔍On this episode of Stem Cell Revolution, host Donna Chang and co-host Jan Shultis unpack how clinical trials actually work. They walk through preclinical animal studies, Phase 1 safety research, Phase 2 efficacy studies often called the valley of death, Phase 3 pivotal trials, and Phase 4 post-market data collection. Only about 8% of investigational products complete that path. Success in a mouse does not reliably translate to people.The conversation focuses on trial design. Endpoints must be locked in before a study begins and cannot be rewritten when unexpected signals appear. Regulators often favor patient-reported outcomes and quality of life, not only imaging or blood tests. Cell therapy adds further complexity: living cells are harder to transport than shelf-stable drugs, and freezing a product to solve logistics can change how it performs at scale.Using lessons from multiple sclerosis and Parkinson’s disease research, they show how dosing intervals, placebo groups, publication standards, and predefined populations can turn promising biology into a public “failure.” They argue every trial should be published, because even unexpected results teach the field how cellular therapy and immune modulation behave in real patients.Understanding these mechanics helps viewers read headlines more carefully and see why regenerative medicine moves slowly, and why careful iteration still matters.What do you think a clinical trial should measure first, how a patient feels or what a scan shows? Comment below and subscribe for more conversations on stem cell research. 💬Learn MoreWebsite: https://www.hope.bio/X (Twitter): https://x.com/hopebiosciencesInstagram: https://www.instagram.com/hope.bio/Facebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences

How do you know if a stem cell therapy is legitimate? In an era of rising interest in regenerative medicine, patients face a flood of claims about cellular therapeutics. This episode of Stem Cell Revolution unpacks the practical questions that help separate credible science from marketing.Host Donna Chang and Jan Shultis walk through a clear framework for evaluating stem cell companies and treatments. They discuss why understanding basic cell biology matters before any conversation with a provider, how to identify cell type and source, and why manufacturing quality control and product-specific data are non-negotiable. Listeners learn the difference between mixed cell populations and pure populations, the importance of donor testing for allogeneic products, and why third-party research cannot substitute for data generated on the actual product being offered.Whether you are exploring options for yourself or a loved one, this episode equips you with the scientific literacy and skepticism needed to ask better questions and make more confident decisions in regenerative medicine.What questions do you ask when evaluating a stem cell treatment? Share your thoughts below and subscribe for more conversations on the science of cellular therapy.Learn MoreWebsite: https://www.hope.bio/X (Twitter): @hopebiosciencesInstagram: @hope.bioFacebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences

As the 2026 World Cup kicks off and America approaches its 250th birthday, Donna Chang and Jan Shultis dig into what contact sports do to the brain — from little league to the pros — how concussions are (and aren't) measured, what the research really says about repeated head impacts and CTE, and where regenerative medicine is heading, including newly published peer-reviewed results in Brain on stem cells for chronic TBI. Honest, data-driven, and built for athletes, parents, and the leagues themselves.

SOURCES & FURTHER READING
Concussion & Injury Scale
•    CDC / “The Epidemiology of Sport-Related Concussion,” PMC — https://pmc.ncbi.nlm.nih.gov/articles/PMC2987636/
•    Sports injury statistics 2025–2026 (AP Sports Editors) — https://apsportseditors.org/sports-injury-statistics/
Head-Impact Exposure by Level
•    Head Injuries & American Football (Ethics Unwrapped, UT Austin) — https://ethicsunwrapped.utexas.edu/case-study/head-injuries-american-football
•    Reducing Head Impact Exposure in HS Football (ClinicalTrials.gov NCT04020874) — https://clinicaltrials.gov/study/NCT04020874
•    CTE Risk Factors / hits per season by level (Headstrong Concussion) — https://www.headstrongconcussion.com/cte-risk-factors
Dose-Response & Risk by Level
•    Mez et al., “CTE risk doubles after 3 years of football,” Annals of Neurology (2019), BU CTE Center — https://www.bu.edu/articles/2019/cte-football/
•    Daneshvar et al., “Number and force of impacts, not concussions, drive CTE risk,” Nature Communications (2023) — https://www.nature.com/articles/s41467-023-39183-0
•    NIH summary: How football raises the risk for CTE — https://www.nih.gov/news-events/nih-research-matters/how-football-raises-risk-chronic-traumatic-encephalopathy
Age of First Exposure & the Young Brain
•    BU CTE Center: youth tackle football & earlier symptom onset (2018) — https://www.bumc.bu.edu/camed/2018/04/30/youth-tackle-football-linked-to-earlier-onset-of-cognitive-and-emotional-symptoms-in-athletes-diagnosed-with-cte-after-death/
•    WashU Engineering: what a lifetime of football does to the brain — https://engineering.washu.edu/news/2020/What-a-lifetime-of-playing-football-can-do-to-the-human-brain.html
•    Bahrami/Whitlow et al., “Subconcussive impacts & white-matter change in youth football,” Radiology (2016) — https://pubmed.ncbi.nlm.nih.gov/27775478/
Measurement & Return-to-Play
•    “The NFL Concussion Protocol: A Review,” PMC — https://pmc.ncbi.nlm.nih.gov/articles/PMC10331260/
•    Baseline concussion testing overview (HeadCheck Health) — https://www.headcheckhealth.com/blog/baseline-concussion-testing
•    Concussion underreporting / baseline screening (ChildServe) — https://www.childserve.org/brain-injury-program/concussion-baseline-screening/
•    Narrative review: return-to-play testing in asymptomatic athletes, PMC — https://ncbi.nlm.nih.gov/pmc/articles/PMC3838723
CTE & Long-Term Outcomes
•    BU CTE Center: CTE found in 345/376 former NFL players (2023) — https://www.bumc.bu.edu/camed/2023/02/06/researchers-find-cte-in-345-of-376-former-nfl-players-studied/
•    McKee et al., “CTE in young contact-sport athletes under 30,” JAMA Neurology (2023) — https://jamanetwork.com/journals/jamaneurology/fullarticle/2808952
•    NIH: CTE identified in young amateur athletes — https://www.nih.gov/news-events/news-releases/cte-identified-brain-donations-young-amateur-athletes
Soccer / Heading (FIELD Study)
•    University of Glasgow FIELD study overview — https://www.gla.ac.uk/schools/healthwellbeing/research/shwimpact/headline_1172079_en.html
•    FIELD 2024: dementia risk not explained by lifestyle — https://www.gla.ac.uk/news/headline_1132176_en.html
Chronic Neuroinflammation After TBI (mechanism)
•    Ramlackhansingh et al., “Inflammation after trauma: microglial activation and TBI,” Annals of Neurology (2011) — https://doi.org/10.1002/ana.22455

As the 2026 FIFA World Cup brings thrilling soccer to stadiums across North America, a quieter but urgent scientific question emerges: what are repetitive head impacts doing to the brains of the athletes we cheer for?In this episode, Donna Chang and Jan Shultis examine the biology of sports-related concussions, the distinction between diagnosed concussions and cumulative head impacts, and the role of persistent neuroinflammation. CDC data indicate 1.6 to 3.8 million sports and recreation concussions occur annually in the US, with millions more likely going undiagnosed. Studies show that the total number and force of head impacts across a career predict chronic traumatic encephalopathy (CTE) far more reliably than the count of diagnosed concussions alone.Listeners will discover why youth athletes face particular vulnerability during critical windows of brain development, how activated microglia drive long-lasting inflammation even after seemingly minor hits, and why symptom resolution does not equal full brain recovery. The conversation also explores emerging research into cellular therapies that may help modulate neuroinflammation, even in older injuries, and the scientific rationale for considering earlier intervention strategies in contact sports.This is essential listening for athletes, parents, coaches, and fans who want to enjoy the World Cup and every game with greater understanding and informed perspective. Science is revealing both the real risks and the pathways toward better protection and recovery.What changes would you like to see in youth and professional sports to better safeguard brain health? Share your thoughts in the comments, subscribe for more episodes on regenerative medicine and brain science, and keep exploring the research shaping the future of athlete care. 🧠⚽Learn MoreWebsite: https://www.hope.bio/X (Twitter): @hopebiosciencesInstagram: @hope.bioFacebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences#FIFAWorldCup2026 #SoccerBrainHealth #ConcussionScience #CTEawareness #Neuroinflammation #StemCellResearch #RegenerativeMedicine #AthleteBrainHealth

In this episode of Stem Cell Revolution, Donna Chang and Jan Shultis examine President Trump’s executive order accelerating psychedelic therapies for serious mental health conditions. They review the historic Oval Office signing, the roles of the FDA and DEA in drug scheduling, and the groundswell of public support—including voices like Joe Rogan and Secretary Kennedy—that helped bring the issue to national attention.The conversation explores how Schedule I substances like MDMA and LSD have been restricted from research and what rescheduling could mean for patient access and clinical trials. Donna and Jan break down Right to Try pathways, overseas treatment experiences, and the balance between safety, dependency risks, and therapeutic potential.This thoughtful discussion offers viewers a scientifically grounded look at how policy changes in one field may inform progress in stem cell research. It underscores the shared need for evidence-based evolution that prioritizes rigorous science while expanding access to promising therapies for chronic conditions.Learn MoreWebsite: https://www.hope.bio/X (Twitter): @hopebiosciencesInstagram: @hope.bioFacebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences#StemCells #RegenerativeMedicine #PsychedelicTherapy #MentalHealth #RegulatoryReform #StemCellResearch #FutureOfMedicine #Biotechnology

In this episode of Stem Cell Revolution, Donna Chang and Jan Shultis dive into the science of aging and longevity. They explore the critical difference between lifespan and healthspan—not just living longer, but living better with greater mobility, independence, and vitality.The discussion covers key biological processes behind aging, including chronic inflammation, cellular senescence or “zombie cells,” and the body’s declining regenerative capacity. They examine how mesenchymal stem cells may help by modulating the immune system, reducing inflammation, and restoring the body’s natural ability to repair itself.Highlights include recent research on stem cell therapy for frailty, the potential for preventative approaches, and why cultured autologous stem cells from your own body can remain highly functional regardless of age. The episode emphasizes scientifically grounded hope for regenerative medicine in addressing age-related decline.Learn what experts are discovering about maintaining vibrant health well into later decades and the future role of cellular therapies in longevity science.Learn MoreWebsite: https://www.hope.bio/X (Twitter): @hopebiosciencesInstagram: @hope.bioFacebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences#StemCells

#Longevity #Healthspan #RegenerativeMedicine #StemCellResearch #CellularTherapy #AgingScience #VibrantAging

Stem cell banking is a multi-billion dollar industry—but what are families actually storing when they bank stem cells?In this episode of Stem Cell Revolution, we break down what adult stem cell banking is and the objectives for storage. We explain what stem cell banks actually store, how different types of stem cells are collected, and what the realistic potential of these cells is in medicine today.We also explain how adult stem cell banking works at Hope Biosciences and how it differs from many traditional stem cell storage models.Stem cells hold enormous promise for the future of medicine—but understanding the science behind how they are collected, processed, and stored is critical for making informed decisions.If you've ever thought about banking your stem cells, this episode is a must-watch!Subscribe for more stories of hope and healing in regenerative medicine! What's your biggest takeaway from this episode? Comment below!Learn More:Website: https://www.hope.bioX (Twitter): @hopebio_orgInstagram: @hopebio_orgFacebook: https://www.facebook.com/HopeBiosciencesResearchFoundationLinkedIn: https://www.linkedin.com/company/hope-biosciences-research-foundationYouTube Channel: https://www.youtube.com/@HopeBiosciencesResearchFoundation#StemCellBanking #RegenerativeMedicine #MesenchymalStemCells #AdultStemCells #HopeBiosciences #StemCellTherapy #MSCs #CellBanking #CultureExpandedCells #StemCellEducation #FutureTherapies #CellularHealth

Why Are Stem Cells So Expensive? The Real Cost Breakdown in 2026

In this episode of Stem Cell Revolution, Donna Chang and Jan Shultis tackle one of the most common and uncomfortable questions in regenerative medicine:

Why do stem cell treatments cost so much?

From $5,000 cash-pay clinic procedures… to $25,000 overseas medical tourism visits… to FDA-approved cellular therapies costing $200,000 to $400,000 — we break down exactly what you’re paying for and why.

This isn’t just a conversation about price tags. It’s about transparency, access, safety, and the future of affordable regenerative medicine.

In this episode, we cover:

• The difference between same-day procedures and true manufactured cell products
• Why many “stem cell” products in the U.S. contain no viable stem cells
• The hidden costs behind overseas treatments and medical tourism
• Why FDA-approved therapies cost hundreds of thousands of dollars
• The real reason hospital-based cellular therapies are so expensive
• How research, testing, and regulatory safeguards impact pricing
• The economics of chronic disease vs regenerative therapy

We also discuss real examples, including:

• Hematopoietic stem cell transplants and why they can cost $400,000
• FDA-approved orthopedic and pediatric cellular therapies
• The recent Mesoblast approval for acute GvHD
• The long-term financial burden of diseases like Parkinson’s, MS, and rheumatoid arthritis

Then we turn to the bigger question:

Is there a way to make stem cell therapy both safe AND affordable?

Donna shares how Hope Biosciences approached the problem differently by focusing first on safety, speed, and standardization to dramatically reduce manufacturing costs without sacrificing quality.

We break down what a monthly regenerative treatment model could look like compared to current biologic drug costs of $60,000 to $100,000 per year.

If you’ve ever wondered:
• Why aren’t stem cells covered by insurance?
• Why do some treatments cost $5,000 and others $200,000?
• Is overseas treatment worth the risk?
• Can regenerative medicine ever be truly accessible?

This episode is essential listening.

The future of stem cell therapy isn’t just about science. It’s about affordability, scalability, and real-world access.

We’d love to hear your thoughts. Drop your questions in the comments and let us know what topics you want us to cover next.

#StemCellRevolution #RegenerativeMedicine #StemCells #CellTherapy #HealthcareCosts #FDA #Biologics #MedicalInnovation #HopeBiosciences

As we kick off the new year, it’s time for a reset.In this episode of Stem Cell Revolution, we reflect on the resolutions regenerative medicine must commit to — not just for the next 12 months, but for the future of the field. From patients and providers to industry, government, and the deeper meaning of hope, this conversation centers on accountability, scientific rigor, and trust.Regenerative medicine holds extraordinary promise but progress depends on the choices we make and the processes we change. Hope without evidence erodes trust. Evidence without compassion misses the point. The future of stem cells depends on holding both at the same time.This episode is an invitation to pause, recalibrate, and move forward collectively and quickly!Subscribe for more updates on the latest in stem cell science and hit the bell 🔔 to never miss an episode!Follow us!WEBSITE - https://www.hope.bioINSTAGRAM - / hope.bio TWITTER - / hopebiosciences FACEBOOK - / hopebiosciences#StemCellResolutions #StemCellRevolution #RegenerativeMedicine #ClinicalResearch #CellTherapy #MSCs #ScienceNotHype #PatientFirst #MedicalInnovation

Join us for our exclusive year-end recap as we celebrate the incredible progress in stem cell therapy throughout 2025! 🚀In this episode, we break down:The Top 3 game-changing moments that defined the yearThe latest clinical program updatesThe inspiring data and statistics showing our progress this year.Whether you're a patient, researcher, or simply passionate about the future of medicine, this episode is packed with insights, optimism, and evidence that the stem cell revolution is accelerating.Don't miss it – watch now and see why 2025 was a pivotal year for regenerative medicine! 💉🧬#StemCellRevolution #StemCellTherapy #RegenerativeMedicine #2025AnnualReport #ClinicalTrials #HopeInTheNumbers #StemCellBreakthroughsSubscribe for more updates on the latest in stem cell science and hit the bell 🔔 to never miss an episode!Follow us!WEBSITE - https://www.hope.bioINSTAGRAM - / hope.bio TWITTER - / hopebiosciences FACEBOOK - / hopebiosciences